Skip to main content
Lucid Software logo

Lucid Software

Security and trust center evidence

lucid.coCollaborationLast verified 17 Sep 2026

Summary

Lucid Software has 3 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 17 Sep 2026, Lucid Software is listed in the FedRAMP registry as FedRAMP Authorized, with authorization issued 07 Sep 2023 and audited by Kratos. As of 17 Sep 2026, Lucid Software is listed in the CSA STAR registry at STAR Level 1 (self-assessment/CAIQ), issued 30 Aug 2021. As of 17 Sep 2026, Lucid Software is listed in the EU-US Data Privacy Framework registry as active across the SW-US, EU-US, and UK Extension certifications, originally issued 12 Oct 2017 and valid through 11 Sep 2027. As of 17 Sep 2026, no public evidence found for SOC 2 or HIPAA for Lucid Software. As of 17 Sep 2026, no subprocessor records were found in the supplied evidence.

  • FedRAMP: listed in FedRAMP registry as FedRAMP Authorized, issued 07 Sep 2023, auditor Kratos (as of 17 Sep 2026).
  • CSA STAR: listed in CSA STAR registry at Level 1 self-assessment (CAIQ), issued 30 Aug 2021 (as of 17 Sep 2026).
  • EU-US Data Privacy Framework: listed in DPF registry as active (SW-US, EU-US, UK Extension), issued 12 Oct 2017, expires 11 Sep 2027 (as of 17 Sep 2026).

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.

Among collaboration vendors

3verified rows

Category median 1, across 22 indexed collaboration vendors. Lucid Software has more verified rows than 100 percent of them.

diagrammingflowchartsvisual-collaborationworkspace

Compliance grid

Subprocessors

No subprocessor list captured yet.

Similar vendors with evidence

Related by product tags and the Collaboration category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.